EZH2 inhibitors enhance effectiveness of cancer immunotherapies

An emerging class of anticancer drugs called EZH2 inhibitors may greatly enhance the potency of some cancer immunotherapies, according to a preclinical study led by Weill Cornell Medicine lymphoma researchers.

Managing the rise in STIs among older adults

A new research review presented at a pre-congress day for this year’s European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024, Barcelona, 27-30 April)

March 28, 2024

Philips, maker of millions of defective sleep apnea machines, ordered to overhaul manufacturing

WASHINGTON — The company responsible for a global recall of sleep apnea machines will be barred from resuming production at U.S. facilities until it meets a

April 9, 2024

Opinion | For Health AI to Fulfill Its Potential, Regulation Is Paramount

Brown is an emergency medicine physician and business expert. Shah is a physician and health AI company executive. Artificial Intelligence (AI) has been used in

November 5, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.